UBS lowered the firm’s price target on Bill (BILL) to $60 from $65 and keeps a Buy rating on the shares. Bill posted a “steady” quarter with limited surprises, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL:
- Bill price target raised to $60 from $55 at JPMorgan
- Bill price target lowered to $48 from $56 at Keefe Bruyette
- Bill.com: Resilient Growth and Emerging Innovations Drive Buy Rating
- Hold Rating on Bill.com Holdings Amid Uncertain Monetization and Competitive Challenges
- Bill.com Reports Strong Q1 2026 Financial Results